Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 307
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05097274 | The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. | ||
| NCT01785992 | A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer. | ||
| NCT05635344 | A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia | ||
| NCT03529669 | Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer | ||
| NCT00337246 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia | ||
| NCT01737242 | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | ||
| NCT04621370 | A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer | ||
| NCT02724163 | International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia | ||
| NCT00985868 | AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors | ||
| NCT01331525 | The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer | ||
| NCT00977210 | Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors | ||
| NCT01303887 | A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients | ||
| NCT04523116 | Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1 | ||
| NCT06380816 | A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer | ||
| NCT04509986 | GlobalSurg-CovidSurg Week | ||
| NCT01586624 | A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1) | ||
| NCT01881386 | Lactate Imaging as a Tumour Biomarker | ||
| NCT04868227 | Scottish Vitamin D Intervention Study | ||
| NCT01233492 | Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme | ||
| NCT03994783 | Transplant Antibody-Mediated Rejection: Guiding Effective Treatments | ||
| NCT00112931 | Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma | ||
| NCT00509561 | Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer | ||
| NCT01654146 | ICON8: Weekly Chemotherapy in Ovarian Cancer | ||
| NCT00555386 | Soy, Selenium and Breast Cancer Risk | ||
| NCT00757263 | Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom | ||
| NCT01118611 | Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors | ||
| NCT03870152 | Electrocautery Ablation for the Prevention of Lung Cancer | ||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | ||
| NCT03150576 | Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer | ||
| NCT01173900 | Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls | ||
| NCT05722886 | DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol | ||
| NCT07279454 | The EAT-FIBRE Study. | ||
| NCT01324115 | NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors | ||
| NCT05628376 | TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO | ||
| NCT00749450 | Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer | ||
| NCT02077569 | AKT Inhibitor in Oestrogen Positive Breast Cancer | ||
| NCT07721740 | Using Patient Navigation to Promote Bowel Screening in AAA Attendees. | ||
| NCT07751133 | Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer | ||
| NCT01556841 | The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer | ||
| NCT02540928 | AMG 319 in HPV Positive and Negative HNSCC | ||
| NCT03479151 | Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU) for Pain Palliation of Bone Metastases | ||
| NCT00433563 | Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer | ||
| NCT01836692 | Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study | ||
| NCT06289374 | Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery | ||
| NCT01140737 | A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas | ||
| NCT04870580 | [18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy | ||
| NCT01147029 | GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy | ||
| NCT03415854 | Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) | ||
| NCT03028766 | WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer | ||
| NCT02741856 | Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation |
